GlassScriptPhysician profile
Aref M Amro
NPI 1740266717
$62,155.28
in general payments reported to CMS, 2019-2025
30 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $560 · 2021: $349 · 2022: $1,494 · 2023: $8,595 · 2024: $37K · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $13K · Food and Beverage: $3,657 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,822.50 |
| Travel and Lodging | $13,093.34 |
| Food and Beverage | $3,657.42 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $40,613.65 | 2021-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $11,893.37 | 2019-2023 | |
| Inari Medical, INC. | $2,084.75 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $1,565.60 | 2019 | |
| Boston Scientific Corporation | $1,514.69 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Opticross |
| Abbott Laboratories | $943.40 | 2023 | Optis, Dragonfly Opstar, Pressurewire |
| Shockwave Medical, INC | $511.05 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Astrazeneca Pharmaceuticals LP | $388.70 | 2019-2023 | Brilinta |
| Medtronic, INC. | $334.21 | 2023-2024 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $301.31 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.70 | 2021-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $179.61 | 2019-2023 | Camzyos |
| Biotronik INC. | $174.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.42 | 2019-2020 | |
| Zoll Circulation INC | $150.00 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $149.67 | 2022-2023 | Ozempic |
| Janssen Pharmaceuticals, INC | $139.19 | 2019-2022 | |
| Amgen INC. | $131.07 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $129.79 | 2019 | |
| Jenavalve Technology, INC. | $112.15 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $92.78 | 2019-2020 | |
| Cardiovascular Systems INC. | $64.34 | 2020 | |
| Abiomed | $61.24 | 2022-2024 | Impella |
| Stryker Corporation | $53.53 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardinal Health 200 LLC | $50.74 | 2019 | |
| Pfizer INC. | $35.69 | 2022-2023 | |
| Cordis US Corp. | $24.02 | 2025 | Mynx Control |
| Teleflex LLC | $17.09 | 2025 | Turnpike |
| Chiesi USA, INC. | $15.50 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $15.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aref Amro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.